ArticleFrontiers in oncology2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T
Magali Rebucci-Peixoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it
ArticleFrontiers in oncology2022
Magali Rebucci-Peixoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.